The large-scale social and behavioural changes that happened almost overnight in our day-to-day life due to COVID-19, illustrate the importance of anticipating and developing new ways of patient care. Especially mobility is a telling sign of how well a patient is doing. “Mobility is something that we take for granted until we lose it. And yet, loss of mobility is a key feature of almost every disease” says Ronenn Roubenoff, Global Head, Translational Medicine Discovery & Profiling, Novartis Institutes for Biomedical Research, and the EFPIA Co-lead of Mobilise-D. The crisis that we are facing now is profoundly changing health care systems around the world and pointing at the importance of accelerating the development of new digital methods for remote patient monitoring.
Digital health will play a more central and essential role in the care and treatments at both the short and long term for patients, payers, and industry. Patients now expect a modern technology experience to mitigate the vulnerabilities of health systems and provide better quality of care. “One of the key objectives of Mobilise-D is to ultimately bring a very simple, low cost technology that can be used in people’s homes to be able to measure their mobility continuously over long periods of time”, says Lynn Rochester, Professor of Human Movement Science, Institute of neuroscience, Newcastle University, and the Academic Lead of Mobilise-D.
See the video below about Mobilise-D during COVID-19 lockdown.